Introduction
X-ray computed tomography (CT) systems with high resolution (also known as micro-CT systems) have been developed over the last two decades and have been used with great success in small animal studies. A micro-CT scanner is based on the same underlying physical principle as a clinical CT scanner, but it is designed for higher-resolution imaging. It produces three-dimensional (3D) tomographic data at microscopic resolution (voxel size ≤100 µm 3 ) by taking hundreds of 2D projections from multiple angles around the animal (Holdsworth and Thornton 2002) . The X-ray source produces a cone beam, which is projected through the specimen with the resultant radiographic density of the specimen projected onto a 2D detector. The projections are used by a reconstruction algorithm that is generally based on the filtered backprojection (Kak and Slaney 1988 ) (see Figure 36 .1). The resultant micro-CT scan is a 3D matrix of voxels with values proportional to the mean linear attenuation coefficient of the material within each voxel; the 3D matrix can be sliced in any orientation to reveal different views of the anatomy.
There are many commercially available micro-CT scanners for in vivo and ex vivo imaging. In vivo scanners are used to scan live animals (mostly mice and rats), while ex vivo scanners are used for imaging dead specimens and materials, such as bone and scaffolds. There are major differences between the two types of scanners.
With in vivo micro-CT instruments, the animal remains alive and available for longitudinal studies, thus reducing the number of animals required. Longitudinal studies can be performed to assess, for example, the effects of diet, drugs, and various treatments on tumors, or bone growth. In vivo micro-CT data are currently also used as a reference for registration with many micro-PET (positron emission tomography) or micro-SPECT (single photon emission computed tomography) scans. For in vivo systems, it is best to have the animal remain stationary during the scan, with its biological measures (e.g. electrocardiogram [ECG] , breathing, temperature) monitored. A heater is used to keep the animal warm during the procedure.
Ex vivo micro-CT instruments typically handle applications such as imaging specific organs of an animal that are excised (such as bone, tumors), biomaterial studies, implants, or material studies. For ex vivo micro-CT scanners, physiological motion is not a concern, so monitoring is not needed. This means that the specimen stage can rotate while the X-ray source and detector are stationary. From an imaging performance standpoint, ex vivo micro-CT instruments allow for higher spatial resolution, better signal-to-noise ratios, and therefore better images compared to in vivo imaging. However, this better imaging performance requires longer scan times and higher dose (since dose to the sample is not an issue for ex vivo scanning).
Consequently, there are advantages to both in vivo and ex vivo micro-CT systems and they can be used as complementary systems, depending on the application.
This chapter provides an overview of these aspects of micro-CT: system components, methods, and applications of micro-CT for small animal studies.
System Geometry
There are two possible system design geometries in micro-CT imaging: (1) rotating gantry (tube and detector) and (2) rotating specimen (see Figures 36.2a and b) . All of the current commercial systems for in vivo scanning use the rotating gantry geometry, that is, they are scaled versions of the clinical CT scanners (see Figure 36 .2a). Using this design, the X-ray tube and detector, which are mounted on a gantry, rotate around an axis, while the X-ray detector 3D images A B
Algorithms
Projections over 360°I mage acquisition
Image reconstruction X-ray tube FIGURE 36.1 The micro-computed tomography (micro-CT) imaging process involves acquiring cone-beam projections with a full rotation of an X-ray source and detector around the animal or specimen. Next, the projections are used by a reconstruction algorithm to create 3D tomographic images. FIGURE 36.2 The two possible design geometries for micro-computed tomography (micro-CT) are based on a rotating gantry (a) or rotating specimen (b). The effect of penumbra blurring: for the same focal spot size (fs) of the X-ray source, the penumbra blurring b is larger when the object is closer to the source (c) than when the object is closer to the detector (d). sod (source-to-object-distance) and odd (object-to-detector-distance). Small Animal X-ray Computed Tomography animal lies stationary on a table between the tube and detector. For most of these systems, the source-to-object distance (sod) is comparable to the object-to-detector distance (odd). A geometrical representation of these distances is shown in Figures 36.2c and d. Positioning the object closer to the X-ray source and farther from the detector allows for an increase in magnification, defined as M = 1 + (odd/sod), which in turn allows for an increase in resolution (provided that the system is based on the use of a small focal spot X-ray source in order to compensate for the penumbra blurring effect). The penumbra blurring describes the unsharpness produced by X-ray tube focal spots. The resolution limit due to penumbral blurring (b) in the projection plane is related to the focal spot diameter (fs), .1, if odd and sod are comparable, as in most of the rotating gantry systems, the penumbra blurring b becomes comparable or larger than the size of the focal spot and could compromise the spatial resolution if the system uses a large focal spot tube. In the case of systems with a rotating specimen, used in most ex vivo scanners (see Figure 36 .1b), the X-ray source and detector are stationary. Such system design is more flexible in changing the magnification by changing the position of the specimen. The specimen could also be placed closer to the detector, that is, odd < sod, resulting in the reduction of penumbra blurring to less than the focal spot size. In this configuration, larger focal spot tubes that provide greater X-ray fluence, and therefore enable shorter exposure times, can be used. Despite these benefits of the rotating specimen design, this type of system has not gained popularity for in vivo imaging, primarily because the animal must be mounted in the vertical position. Combining the benefits of an object magnification and rotating gantry design, some commercial systems with odd < sod (M = 1.3) have also become available , Du et al. 2007 ) to allow rapid dynamic micro-CT, albeit at the price of reduced resolution.
System Components

X-ray Sources
The choice of the X-ray source strongly affects micro-CT system performance. Due to the tradeoff between focal spot size and thermal loading of the source's metallic anode, most X-ray tubes with micro-focus tubes (focal spot diameter: <∼50 µm) operate with very low photon output (in the order of 100-times lower) compared to the high-power tubes used in clinical scanners (Badea et al. 2004b ). This fact explains the increase in the average scan time required in micro-CT compared with clinical scans.
The most-used X-ray sources for micro-CT are micro-focus, fixed tungsten anode tubes operating in continuous mode, with voltages in the range of 20-100 kV and anode currents in the range of 50-1000 µA. In vivo micro-CT systems working at low magnification often use pulsed X-ray sources with higher power and wider focal spots, in the range of 0.3-0.6 mm. The use of pulsed X-ray sources is especially important for prospective ECG gating (Badea et al. 2008b ). This type of imaging can also be done with sources operating in continuous mode by using external shutters.
For ex vivo imaging of small biological samples at very high magnification, the need for very small focus is more important because it represents a major influencing factor of the spatial resolution. Reflection-anode X-ray tubes with focal spots in the range of 5-20 microns are available on the market. Because of the very high power density that such narrow electron beams can release on the target surface, the anode current must be controlled as a function of focal spot size to prevent melting (Grider and Erway 1986) . The maximum anode currents in most microfocus X-ray tubes are in the order of 100-200 µA, with maximum power <10 W. Other drawbacks of reflection-type X-ray sources with thick targets include a relatively narrow aperture of the cone beam (in the range of 30-60°) and a limited capability of reducing the focus-to-object distance below a few millimeters. Non-uniformity of the beam intensity due to the heel effect can be reduced by flat-field (gain) correction; however, accounting for the variation in the X-ray spectrum across the beam profile is difficult (Fivez et al. 1996) . Open-type sources with thin-target transmission anodes overcome these limitations, providing radiation beams with angular apertures in the range of 140-160° with the possibility of putting the object virtually in contact with the focus. However, the back of transmission targets cannot be cooled with liquid, reducing the maximum possible power per unit area compared to reflection anodes. The spatial resolution obtainable with this type of source can be <1 micron, which is similar to synchrotron-based imaging. Nevertheless, synchrotron-based micro-CT and nano-CT are still superior to laboratory-level micro-CT and nano-CT systems in terms of contrast resolution and signal-to-noise ratio because synchrotrons provide tunable, monochromatic radiation, avoiding beam hardening artifacts, and much higher photon fluxes, reducing noise (Ritman et al. 1997 , Brunke et al. 2008 , Stolz et al. 2011 .
Other X-ray tube designs have been proposed. Cao et al. have investigated the use of a compact field-emission micro-focus X-ray source based on carbon nanotubes (Cao et al. 2009 (Cao et al. , 2010 . In this type of source, the metal filament cathode is replaced by a field-emission cathode that is capable of emitting electrons at room temperature with voltage controlled output current (Yue et al. 2002) .
X-ray Detectors
There are two categories of micro-CT X-ray detectors:
(1) energy-integrating and (2) energy-discriminating detectors. The majority of detectors used in micro-CT scanners are energyintegrating. Most micro-CT systems to date employ digital flatsurface 2D detectors leading to a cone-beam scanning geometry. Early prototype micro-CT systems employed X-ray image intensifiers read by charge-coupled devices (CCDs) (Feldkamp et al. 1989 , Boone et al. 1993 , Holdsworth et al. 1993 . Later, in the mid-nineties, combined detection systems made up of scintillator screens coupled to CCDs via fiber-optic bundles, with various de-magnifying ratios, became the standard for micro-CT imaging (Paulus et al. 2000 , Goertzen et al. 2004 .
More recently, advances in complementary metal oxide semiconductor (CMOS) technology led to the production of large area detectors with high frame rates, which are the most widely used systems for in vivo, small animal imaging (Lee et al. 2003, Kalender and Kyriakou 2007) . Cooled CCDs are still in use, especially in applications involving low X-ray fluences, due to their very low dark noise with respect to flat-panel CMOS detectors. Also reported in the literature are studies on the use of direct conversion detectors coupled to thin-film transistor (TFT) arrays (Goertzen et al. 2004 ) and of single-pixel or small area detectors operating in photon counting mode (Paulus et al. 2000 , Panetta et al. 2007 ) for small animal micro-CT.
The energy discriminating photon-counting X-ray detectors (PCXD) are the subject of intensive research and promise to make spectral CT a reality. In fact, micro-CT is the testing stage for spectral CT using PCXD (Taguchi and Iwanczyk 2013) . PCXDs with energy binning can improve CT performance by counting and binning each X-ray detected into a number of energy bins equal to the number of energy thresholds per pixel. PCXDs allow for the elimination of dark noise in the image by rejecting all counts below the signal and also allow for spectral separation. The technology, currently in its infancy, is set to grow rapidly. Sensor materials for PCXDs include silicon (Si), gallium arsenide (GaAs), and cadmium telluride (CdTe) with pixel sizes as small as 55 µm (Taguchi and Iwanczyk 2013 ). Yet, there remain technical limitations to spectral detectors that preclude their immediate replacement of conventional, energy-integrating detectors for biomedical CT applications (Taguchi et al. 2011) . For example, Si is an X-ray detector material with fast signal collection and low susceptibility to signal pile-up, but suffers from a high fraction of Compton interaction at X-ray energies encountered in CT practice, degrading its spectral imaging capabilities (Bornefalk and Danielsson 2010) . Among the best available PCXDs, the Medipix detectors have a small pixel size and are best suited for imaging of small animals in preclinical applications (Yu et al. 2012, Taguchi and Iwanczyk 2013) . Medipix is a series of photon-counting detectors for X-ray micro-imaging from the Conseil Européen pour la Recherche Nucléaire (CERN) (Campbell et al. 1998 ). There are already multiple generations of this PCXD. Medipix1 had a pixel size of 170 × 170 µm. Medipix2 reduced the pixel size to 55 × 55 µm. The performance of Medipix2 was limited by charge-sharing over neighboring pixels, compromising energy resolution. Medipix3 addressed this problem using a photon-processing chip with special circuitry to allow charge deposition in adjacent pixels to be summed and analyzed with two simultaneous energy thresholds and without spectral distortion (Yu et al. 2012) . The readout logic supports eight energy thresholds over 110 × 110 µm for spectroscopic imaging. A commercially available micro-CT system (MARS; University of Canterbury, Christchurch, New Zealand) is equipped with Medipix3 detectors. We review spectral micro-CT in separate Section 36.12.
The projection raw data from the X-ray detector are first preprocessed to compensate for the imperfectness of the system, for example, detector response heterogeneity, X-ray flux intensity drift, defective pixel correction, dark current subtraction, and mechanical geometry calibration.
Geometric Calibration
Successful micro-CT imaging is conditioned by an accurate knowledge or calibration of the sampling geometry, also known as alignment. Due to requirements of very high resolution for micro-CT, the allowed mechanical tolerances in geometric variables such as the source-to-detector distance, source-to-object distance, the tilting angles of the detectors, or axis of rotation, are on the same order of magnitude of the thermal drifts of the components (Parkinson and Sasov 2008 ). An uncorrected displacement of the axis of rotation of a tenth of the detector pitch may result in a significant image blurring, and consequently, in a loss of image spatial resolution. Many methods have been proposed for the measurement of the misalignment parameters from the analysis of the acquisition data in cone-beam geometry (Noo et al. 2000 , Beque et al. 2003 , von Smekal et al. 2004 , Yang et al. 2006 , Defrise et al. 2008 . Such parameters can be embedded into the reconstruction process via a projection matrix in order to produce misalignment free reconstructed images (Karolczak et al. 2001) .
Most geometric calibration methods make use of a phantom consisting of two or more small spherical objects, such as metallic beads; each bead traces an ellipse on the detector plane during the tomographic acquisition, hence the geometry of the tomographic system can be determined by the analysis of all the ellipses.
Despite their accuracy, a drawback of the calibration methods based on special phantoms is that they need dedicated acquisition sessions to be applied. Many commercial systems for micro-CT imaging now provide zoom-in capability and variable geometry. In such cases, nearly continuous calibration of the system's geometry is necessary to guarantee the stability of the image spatial resolution. For this purpose, methods of selfcalibration have also been developed that attempt to estimate a subset of the geometric parameters of the system from the projection data of a generic object (Panetta et al. 2008) or by postreconstruction optimization of image-based metrics of image sharpness (Wicklein et al. 2012) .
Image Reconstruction
All CT image reconstruction algorithms solve an inverse problem that maps cone-beam projection data to a 3D tomographic representation of the specimen (Paulus et al. 2001 ).
There are two major types of algorithms: (1) filtered back projection (FBP)-based algorithms, and (2) iterative algorithms (Kak and Slaney 1988) . The most commonly used reconstruction algorithms in CT and micro-CT are based on FBP. In FBP, the acquired, 2D, cone-beam projections are filtered, using a convolution kernel that reduces the blurring inherent to the back projection process, and then they are back projected (i.e., smeared back) through the object space at the appropriate angle to generate an image. While first developed for 2D imaging (parallel or fan beam), convolution back projection was adapted by Feldkamp (Feldkamp et al. 1984) to compensate for the conebeam geometry. This method forms the basis for the reconstruction algorithms used in most current micro-CT systems. While Feldkamp's algorithm is considered to be an approximation, since the circular sampling trajectory does not satisfy Tuy's data sufficiency condition (Tuy 1983 ), the quality of the reconstructed images is acceptable if the cone angle <10° (Holdsworth and Thornton 2002) , except for very unusual object configurations (Defrise and Clack 1995) .
When the number of projections available for reconstruction is limited and/or the projections are very noisy (e.g., low dose scanning), both iterative and statistical reconstruction algorithms can provide notably better image quality than FBP. Reduction in the number of views translates directly to reduced radiation dose to the animal. Furthermore, it is sometimes not possible to acquire projections with regular-angular sampling in dynamic imaging applications such as cardiac studies. In such cases, the reconstruction is affected by artifacts when FBP is used. Iterative algorithms, such as the algebraic reconstruction technique (ART) (Gordon et al. 1970) , present an alternative to FBP with the potential for robust reconstruction given less than ideal projection data (Kak and Slaney 1988) . With such algorithms, the reconstructed volume is refined by repeatedly comparing simulated re-projections of the reconstructed volume with the original projections.
Artifacts from FBP reconstruction with an irregular-angular distribution of projections manifest as long thin streaks and shading artifacts. Total variation (TV) regularization has been recognized for its ability to suppress artifacts, while leaving boundaries between homogeneous regions intact (Rudin et al. 1992) . TV regularization can be interleaved with iterative reconstruction algorithms such as the simultaneous algebraic reconstruction technique (SART) by performing one or more iterations of each in turn. To illustrate the power of SART-TVbased reconstruction using irregularly sampled projections, we present its application in 4D cardiac micro-CT. Specifically, Figure (Song et al. 2007) .
Statistical image reconstruction is another class of iterative reconstruction algorithms, first introduced for transmission imaging in nuclear medicine, but also applied for CT reconstruction (Elbakri and Fessler 2002) . In essence, these algorithms treat the reconstruction as a statistical estimation problem and have the advantage that they can accurately model Poisson noise in the projection data. This results in lower noise levels with statistical reconstruction for the same data when compared with FBP reconstruction.
One major limitation of iterative reconstruction algorithms is their running time. To overcome this limitation, the graphics processing unit (GPU) has been recognized as an alternative computer architecture with potential for accelerating CT reconstruction (Xu and Mueller 2007) . This parallel architecture is ideal for CT reconstruction steps in which the same arithmetic operations must be performed at multiple pixels or voxels (e.g. projection, back projection). The development of programming tools for general-purpose computing on the GPU, such as NVIDIA's Compute Unified Device Architecture (CUDA, Santa Clara, CA), has facilitated the acceleration of CT reconstruction, presenting the opportunity to explore more complex iterative algorithms. Micro-CT is already benefiting from GPU-based implementations of analytical, iterative, and statistical image reconstruction (Zhao et al. 2007 , Jakab et al. 2009 , Johnston et al. 2010a ).
Cardio-Respiratory Gating in Small Animal Micro-CT
The influence of cardiac and respiratory motion during in vivo scanning can be minimized by using cardio-respiratory gating. 4D micro-CT used in cardio-pulmonary studies typically employs either prospective gating (PG) or retrospective gating (RG). In PG, acquisition is triggered by the coincidence of a selected respiratory phase and a selected cardiac phase. This produces a set of projections with a constant angular step, resulting in reconstructed images that are free of streaking artifacts. However, because of the time spent waiting for the coincidence of cardiac and respiratory events, the scan time can take as long as one hour to cover 10 different phases of the cardiac cycle (Badea et al. 2004b ).
In RG, the projection images are acquired at a rapid and constant rate without waiting for cardiac and respiratory coincidence. Respiratory and ECG signals are monitored and saved in synchrony with the acquisition of the projections. Using these signals post-sampling (i.e., retrospectively), the projections are sorted into different subsets corresponding to different cardiac and respiratory phases. With this protocol, the scan time can be shortened to 50 seconds when using a slip ring gantry ). However, the irregular angular distribution causes streaking artifacts in the FBP-based reconstructed images. As shown by Figure 36 .3, superior results are possible using regularized iterative algorithms such as SART-TV (Song et al. 2007) . A different gating strategy called fast prospective gating (FPG) has been introduced (Guo et al. 2012a) , which combines the regular angular distribution of PG with the fast scan time of RG. In FPG, multiple projections are acquired at the same angle, corresponding to all cardiac or respiratory phases to be reconstructed, before the cradle is rotated to the next angle. FPG requires onthe-fly computation of the triggering events, which are delayed from the peaks of the respiratory or cardiac signals.
In terms of implementation, most of the proposed methods involve extrinsic cardio-respiratory gating, in which the cardiac and respiratory signals are acquired with dedicated monitoring devices (i.e., ECG leads and a pneumatic respiratory pillow). In addition to these extrinsic gating techniques, an intrinsic imagebased gating approach without any external devices was developed, initially for a clinical, spiral cone-beam CT scanner (Kachelriess et al. 2002) . In intrinsic gating, a post-processing algorithm evaluates the center of mass of certain regions of interest (ROIs) within each projection to detect respiratory and cardiac motion (Bartling et al. 2008 , Sawall et al. 2011 .
Applications of Non-ContrastEnhanced Micro-CT
Micro-CT images only demonstrate high contrast when there are large differences between material densities (Compton scattering) or atomic weight (photoelectric effect) within the subject. In the case of soft tissue imaging, there is very little natural contrast, and an exogenous high atomic weight contrast agent must be administered for effective imaging (Yu and Watson 1999) . However, non-contrast-enhanced micro-CT performs well for bone, lung, or even helps in brain studies, in the absence of exogenous contrast agents.
Bone Imaging
Bone imaging was one of the very first common applications of micro-CT for small animal imaging (Feldkamp et al. 1989 , Kinney et al. 1995 . Micro-CT is well-suited for bone imaging because of the natural contrast between bone and soft tissues, which is due to the higher effective atomic weight of bone. This makes micro-CT extremely valuable for non-invasive, highresolution bone imaging without the need for an exogenous contrast agent. Micro-CT can accurately quantify a variety of bone parameters, including cross-sectional area, cortical thickness, bone mineral density, bone volume, bone surface ratio, and trabecular thickness (Bouxsein et al. 2010 ). Structural micro-CT studies have examined bone architecture (Waarsing et al. 2005 , Hsu et al. 2014 , bone remodeling (David et al. 2003 , Cowan et al. 2007 , and osteoarthritis (Appleton et al. 2007 , McErlain et al. 2008 . Micro-CT has also been used to monitor bone healing after treatment with basic fibroblast growth factor (Yao et al. 2005) , vascular endothelial growth factor gene therapy (Li et al. 2009 ), or stem cell therapy (Lee et al. 2009 ). Micro-CT can also be used to longitudinally track bone loss and structural changes following radiation therapy and bone marrow transplantation (Dumas et al. 2009 ) or after spinal cord injury (Jiang et al. 2006 ). In the case of osteoporosis, micro-CT measurements have been used to study disease progression after ovariectomy (Laib et al. 2001) or immobilization (Laib et al. 2000) . Micro-CT has also been used to study early bone development and growth (Guldberg et al. 2004 ). Additionally, micro-CT has been used extensively in studies of bone regeneration (Umoh et al. 2009 ) and bone tissue engineering (Lin et al. 2005, Ho and Hutmacher 2006) . In these cases, micro-CT can quantify mineral content, porosity, and connectivity, as well as accurately determine 3D structures. Figure  36 .4 illustrates ex vivo micro-CT bone imaging at various resolutions (Bouxsein et al. 2010) . Note that structural bone details are lost as the resolution gets worse. This points to the importance of high resolution being required in bone studies. 
Lung Imaging
The large difference in density between air-filled lungs and soft tissues creates high contrast for lung imaging, which also makes CT an extremely useful modality for studying the lung. The primary difficulty in imaging the lungs is respiratory motion. Small-animal breathing rates are three to four times the average respiratory rate for humans, so completing an entire scan between breaths is not practical. Instead, various gating strategies are used, which allow researchers to acquire each projection at the same stage in the respiratory cycle, so that there is only minimal motion from one projection to the next. One of the most effective methods of respiratory gating is to intubate the animal and control the respiration by mechanical ventilation Johnson 2002, Namati et al. 2006 ). This allows projections to be acquired at exactly the same point in each respiratory cycle. The X-ray projections can then be acquired automatically at the same point in the measured respiratory cycle (Badea et al. 2004a ). For a less invasive approach, the respirations of a freely breathing animal can be monitored using a pressure transducer. This method does not perfectly eliminate respiratory motion, but it is much less invasive than mechanical ventilation and can still resolve features down to ∼150 microns (Namati et al. 2006 ). Retrospective gating is also possible, in which many projections are acquired rapidly and sorted post-acquisition according to the phase of the respiratory cycle. Subsequently, these sorted projections are used for the reconstruction of tomographic images corresponding to each phase of the respiratory cycle ). Micro-CT has been used to study a wide variety of lung diseases. Micro-CT can be used to longitudinally monitor mice for the presence of lung metastases (Li et al. 2006) , as well as follow the growth of lung tumors (Hori et al. 2008 , Namati et al. 2010 , Li, et al. 2013a , Rudyanto et al. 2013 ). The treatment efficacy of chemotherapy (Ueno et al. 2012) or radiation therapy (Perez et al. 2009 , 2013 ) on lung tumors can be measured using micro-CT, and lung injury resulting from radiation therapy can also be assessed (Saito and Murase 2012) . In addition to tumor characterization, micro-CT is also useful for imaging diseases of the lung parenchyma. Mouse models of emphysema created by intra-tracheal instillation of elastase (Postnov et al. 2005 , Artaechevarria et al. 2011 , De Langhe et al. 2012 , MunozBarrutia et al. 2012 or exposure to cigar smoke (Sasaki et al. 2015) have been developed and characterized by micro-CT. In emphysema, CT values decrease compared to normal lung due to the loss of soft tissue parenchyma and increased air-trapping.
A mouse model of bleomycin-induced lung fibrosis has also been studied extensively by micro-CT (Shofer et al. 2007 , Shofer et al. 2008 , De Langhe et al. 2012 , and this model has been used with micro-CT for the preclinical evaluation of drug efficacy (Scotton et al. 2013 , Zhou et al. 2015 . In fibrosis, micro-CT values increase due to an expansion of the parenchyma tissue. Lung compliance and lung volume, which are important factors in both emphysema and fibrosis, can also be measured by micro-CT. Animals are mechanically ventilated at multiple pressures and the lung volume at each pressure is measured. The resulting lung pressure-volume curve can be used to calculate lung compliance (Guerrero et al. 2006 , Shofer et al. 2007 . Figure  36 .5 shows an example of longitudinal lung micro-CT imaging in a control and a mouse with bleomycin-induced fibrosis at one week post-instillation (Shofer et al. 2008) . The micro-CT images were acquired both at end-expiration and end-inspiration using respiratory gating. In the fibrosis mouse, the images show dense consolidation at expiration with ground-glass opacities at inspiration. Furthermore, there is limited movement of the diaphragm, suggesting reduction in lung volumes at end-inspiration.
Brain Imaging
A lack of significant contrast often poses a barrier to the imaging of brain disease models with non-contrasted micro-CT. However, since the brain resides in a cavity that is circumscribed by the cranial bones of the skull, micro-CT can become useful. For example, micro-CT has been used to locate metallic electrodes in the brain for neural recording studies (Borg et al. 2015) . Simultaneous neural recordings taken from multiple areas of the rodent brain can provide insight about spatially distributed neural circuitry. The traditional methods for localizing the precise location of surgically implanted metallic electrodes into intact rodent brains require slicing and staining of physical brain tissue, and are cumbersome. But, micro-CT localization FIGURE 36.5 Representative micro-computed tomography (micro-CT) images at end expiration and end-inspiration of a control mouse (a) and a mouse with fibrosis at week 1 (b). Note darkening of lung parenchyma, diaphragmatic depression, and enlargement of the airways present in the control mouse (a). In week 1 fibrosis mouse (b), there is dense consolidation in the expiratory images with ground-glass opacities at end-inspiration in the peripheral and lower lung fields with persistent consolidation apically. In addition, there is limited movement of the diaphragm, suggesting reduction in lung volumes at end-inspiration.
can provide a better solution. Figure 36 .6 presents examples of micro-CT images used for electrode localization. Being metallic, note that the electrodes produce streaking artifacts. Using adequate metallic artifact reduction techniques can make these micro-CT images sufficient for registration to a magnetic resonance imaging (MRI) brain atlas, and thus provide accurate localization of the electrodes in known brain structures.
Micro-CT Contrast Agents
Due to lack of inherent contrast for soft-tissue imaging, the majority of CT scans make use of high atomic weight contrast agents. In current clinical practice, iodine is the most commonly used element for intravascular CT contrast. Iodine contrast agents are made up of water-soluble aromatic iodinated compounds. These compounds provide effective contrast due to their high atomic number, which produces a strong photoelectric effect. Because CT is relatively insensitive to contrast, high concentrations of contrast agent (up to 400 mg iodine/mL) must be injected to produce adequate image enhancement. Clinical CT contrast agents are generally safe, but severe adverse reactions sometimes occur due to their high osmolality and high viscosity (Namasivayam et al. 2006 , Tepel et al. 2006 , Wang et al. 2007 ). Iodinated contrast agents are rapidly cleared from the bloodstream by the kidneys (Bourin et al. 1997) , so there is only a very short window for imaging after injection. Additionally, these agents quickly distribute from the intravascular to the extravascular space throughout the body. Initially, this provides useful contrast, but after a short time, this nonspecific uptake leads to uniform enhancement throughout most of the body.
For small-animal imaging, the use of clinical contrast agents is particularly difficult. Small animals have much higher renal clearance rates than humans, so injected contrast agents are rapidly excreted. This can be illustrated for a mouse. In the average adult mouse, blood volume is approximately 1.5-2.0 mL (Diehl et al. 2001) , and the glomerular filtration rate (the volume of plasma filtered by the kidneys per time) is approximately 0.4 mL/s (Cervenka et al. 1999) . Therefore, the whole mouse blood volume is filtered by the kidneys in less than five seconds. Consistent with this filtration rate, it has been shown that clinical iodine contrast agents drop to undetectable levels in the bloodstream within four seconds of injection in a mouse (Lin et al. 2008) . This rapid clearance of contrast agent severely limits the useful application of clinical contrast agents in small animals.
To overcome the rapid clearance of traditional contrast agents, blood pool contrast agents have been developed, which exhibit prolonged blood residence time and stable enhancement for minutes to hours. Blood pool agents are made up of a wide variety of high molecular weight compounds or nanoparticles that avoid renal clearance due to their large size. Iodine-based blood pool agents include iodine-containing polymers (Galperin et al. 2007 , Aviv et al. 2009 ), micelles (Trubetskoy et al. 1997 , Torchilin et al. 1999 ), emulsions (de Vries et al. 2010 , Hallouard et al. 2013 , Li et al. 2013b , and liposomes (Krause et al. 1993 , Petersein et al. 1999 , Mukundan et al. 2006 . The development and use of these iodine-containing blood pool contrast agents have been reviewed elsewhere (Hallouard et al. 2010 , Cormode et al. 2014 , Li et al. 2014 . Some iodine-containing blood pool agents are commercially available for small animal research, including Fenestra ® (MediLumine) and Exia ™ (Binitio Biomedical, Inc.).
Over the past several years, metal nanoparticle contrast agents have been developed, which incorporate a wide variety of elements. The most commonly used metal nanoparticles for micro-CT consist of gold. Gold nanoparticles produce greater CT enhancement than iodinated contrast agents because of the high atomic number of gold (Z = 79) compared to iodine (Z = 53). Gold nanoparticles are particularly promising for in vivo imaging applications because gold is extremely inert and gold nanoparticles can be readily modified with surface-linked molecules to render them biocompatible . Surface conjugation is important for nanoparticle contrast agents, because bare nanoparticles adsorb serum proteins and are readily recognized and cleared by the immune system. A variety of molecules can be added to the nanoparticle surface to decrease nanoparticle clearance, but the most common modification strategy is the addition of polyethylene glycol (PEG) (Jokerst et al. 2011) . Surface PEGylation and size significantly increases the blood residence time of nanoparticles, which allows them to be used as blood pool contrast agents. Nanoparticles for micro-CT have also been developed using other metals, including silver, barium, gadolinium, bismuth, ytterbium, tantalum, and thorium (Jakhmola et al. 2012 ).
Applications of Contrast Enhanced Micro-CT
The development of nanoparticle contrast agents has opened the door for many exciting applications in small animal imaging. While imaging applications using low molecular weight contrast agents have been limited, blood pool contrast agents have now been used for a wide range of imaging applications. Important modern applications for contrast-enhanced micro-CT in small animals include imaging of the vasculature, heart, liver, abdomen, and tumors. Current research of micro-CT contrast agents is now focused on developing agents with active targeting, multimodal, or theranostic capabilities.
Vascular Imaging
Vascular imaging for micro-CT is done primarily using blood pool contrast agents. Micro-CT scan times must be longer than clinical CT scan times due to the requirement for much higher resolution. Higher resolution implies a need for more X-ray flux, which is achieved with longer integration time per projection. Early micro-CT scanners required up to an hour to complete a scan. In these cases, low molecular weight contrast agents could not be used for vascular imaging, as they would be cleared from the bloodstream long before the image acquisition was completed. For current micro-CT scanners, scan times of under a minute are now possible. Using these fast protocols, low molecular weight contrast agents have been successfully used for vascular imaging (Kiessling et al. 2004 , Schambach et al. 2010 ). However, these contrast agents must be either repeatedly or continuously administered over the course of a scan to achieve a constant level of vascular enhancement. This increases the difficulty of imaging and may significantly increase the injected dose of contrast agent. As an alternative to low molecular weight contrast agents, blood pool contrast agents have been successfully used for a variety of vascular applications, including measurements of vascular morphology, diameter, and branching (Vandeghinste et al. 2011) , imaging pulmonary vasculature (Johnson 2007) , imaging hepatic vasculature (Chouker et al. 2008 ), imaging tumor vasculature , Graham et al. 2008 , and measuring vascular permeability (Langheinrich and Ritman 2006 ). By providing a constant level of enhancement within the vasculature over a prolonged period of time (minutes to hours), these contrast agents simplify the acquisition of vascular images using micro-CT and allow for a wider range of imaging protocols to be used. Figure 36 .7 shows examples of vascular imaging both in vivo and ex vivo. In Figure 36 .7a, micro-CT was used with a liposomal iodine contrast agent in order to study the vasculature associated with primary soft tissue sarcomas of the hindlimb . Maximum intensity projection is used to render the vascular component. In Figure 36 .7b, we present an ex vivo case. The mouse lungs were perfused with Microfil medium mixture through the pulmonary artery at 3 mL/min. The study was focused on investigating how beta-arrestins regulate signaling by bone morphogenetic protein type II receptor in pulmonary arterial hypertension (Rajagopal et al. 2011 ).
Cardiac Imaging
Cardiac imaging is challenging in small animals due to their rapid heart rate (∼600 bpm for mice). Like respiratory gating (see Section 36.6), cardiac gating can be used to minimize artifacts due to cardiac motion in the resulting CT images. Cardiac gating can be performed either prospectively (Badea et al. 2005 , 2008a , Ford et al. 2005 , Guo et al. 2012a or retrospectively (Bartling et al. 2007 , Song et al. 2007 , Badea, et al. 2008b ,c, Badea et al. 2011c , Ashton et al. 2014a ). In both cases, the ECG of the animal is continuously monitored. In prospective gating, each projection is triggered at a pre-defined point of the cardiac cycle, so that the heart is in the same position in each of the projections. In retrospective gating, projections are acquired rapidly over several rotations and then the timing of the images is compared to the ECG signals. Each of the projections is next sorted according to its cardiac phase and used for tomographic reconstruction. Retrospective gating is much more rapid but produces an irregular angular distribution of projections, which can cause artifacts during the reconstruction process. Because prospectively gated images are acquired using temporal delays computed based on the ECG signal, they require several minutes to perform. Many cardiac imaging protocols incorporate both respiratory and cardiac gating to minimize overall thoracic motion during the scan (Badea et al. 2004a ). We note that intrinsic retrospective gating can also be implemented with cardiac and respiratory motion signals derived from information within each of the acquired projections using image processing, thus avoiding the complications of having ECG or respiratory sensors attached to the mouse (Bartling et al. 2008 , Kuntz et al. 2010 , Johnston et al. 2010b ). For all cardiac imaging, contrast agents are necessary to differentiate the myocardium from the heart lumen. Because cardiac-gated scans can require several minutes to perform, enhancement of the blood within the heart must remain constant for a prolonged period of time to produce high-quality scans. Such imaging is possible with low molecular weight contrast agents by using continuous infusion during the scan or repeated injections (Sawall et al. 2012 ), but the vast majority of studies have made use of blood pool contrast agents. Because images can be acquired over multiple phases of the cardiac cycle, cardiac micro-CT can produce 4D images of the beating heart. These datasets can be used to measure cardiac function, including ventricular volumes, stroke volume, ejection fraction, wall motion, and cardiac output (Wetzel et al. 2007 , Badea et al. 2005 , 2007 , 2008c . Measurements of cardiac function by micro-CT can be used, for example, to evaluate the effect of drugs such as dobutamine-induced cardiac stress (see Figure 36 .8a (Badea 2011b) ). Cardiac micro-CT can also be used to longitudinally measure changes in cardiac function over time. For example, left ventricular remodeling following a coronary ligation-induced myocardial infarction has been tracked by micro-CT (Sheikh et al. 2010) . Measurements of cardiac function and infarct size have also been performed in coronary ligation mouse models using either a combination of blood pool agent and a low molecular contrast agent (Nahrendorf et al. 2007 ) or a blood pool contrast agent (Exia 160), which shows specific uptake in myocardium (Ashton et al. 2014a ). An example of micro-CT imaging of myocardial infarction using a delayed hyper-enhancement protocol in a rat, as described in Nahrendorf et al. 2007 , is shown in Figure 36 .8b.
Liver Imaging
Blood pool contrast agents, which avoid renal clearance due to their large size (>6 nm), are eventually cleared from the bloodstream by phagocytic cells in the reticuloendothelial system (Moghimi et al. 2001 ). This clearance occurs primarily in the liver and spleen, which leads to accumulation of contrast in those organs over time. This provides high enhancement of these organs for liver and spleen-specific imaging. One of the commercially available micro-CT contrast agents, Fenestra LC (http:// www.medilumine.com/), is composed of iodinated phospholipids, which are recognized by the ApoE receptor on hepatocytes and internalized in the liver, which provides additional specificity for liver imaging. Because these blood pool contrast agents are taken up by normal-functioning liver and spleen, they can be used to identify necrotic regions (Chouker et al. 2008) , liver tumors (Almajdub et al. 2007 , Montet et al. 2007 , Desnoyers et al. 2008 , Graham et al. 2008 , Kim et al. 2008 , Boll et al. 2011b , and spleen tumors (Almajdub et al. 2007) , as well as to measure organ volume, quantify hepatic necrosis (Varenika et al. 2013) , and determine liver anatomy (Fiebig et al. 2012) . shows slices in a coronal orientation of a liver in mice with HT-29 colon adenocarcinoma tumors (Pandit et al. 2013) . The mouse was injected with a liposomal iodinated contrast agent and imaged one day and five days post-injection. The tumors appear hypo-enhanced relative to normal liver parenchyma.
Kidney Imaging
Micro-CT imaging of the kidneys can provide important anatomical and even functional data. Because any low molecular weight iodinated contrast agents undergo renal excretion, contrast enhancement of the kidneys is straightforward. Thus, abnormalities like renal cysts are readily detected and measured during longitudinal studies (Xu et al. 2013) . Research on mouse models for renal diseases, such as polycystic kidney disease, also use micro-CT (Wilson 2008) . Micro-CT allows accurate measurements of kidney volume (mm 3 ), length (mm), and thickness (mm) (Almajdub et al. 2008) . Figure 36 .10 presents a maximum intensity projection of both kidneys and a coronal micro-CT slice through one of the kidneys. Note that the renal pelvis (inner core structure) is immediately distinguishable from the renal cortex (outer rim) and medulla (intermediate space in between).
Gastrointestinal Imaging
Micro-CT has demonstrated its usefulness in detecting colon lesions in mouse models of cancer. Negative contrast-enhanced micro-CT imaging of murine models of colonic tumors has proven to be useful for detecting lesions <2 mm, validating the modality as a longitudinal imaging platform for investigating the disease (Pickhardt et al. 2005 , Durkee et al. 2008 . Other studies have investigated the efficacy of multiple contrast-enhanced experiments for detecting colon malformations. A combination of intraperitoneal (IP) injected with rectally-administered iodinated contrast agents was used for detecting colon tumors (Choquet et al. 2007 ).
Barium sulfate (BaSO 4 ) solution is a contrast agent used for imaging the gastrointestinal (GI) tract. In clinical use, BaSO 4 is suspended and then ingested orally for upper-GI imaging, or a BaSO 4 solution is administered rectally for lower-GI imaging. BaSO 4 coats the lining of the esophagus, stomach, and intestines for a length of time sufficient for CT imaging. Figure 36 .11 presents examples of GI imaging using micro-CT with BaSO 4. (Wathen et al. 2013) . Polyps in the colon can also be detected by using an administration of BaSO 4 followed by air used as a negative contrast agent for the bowel space (Boll et al. 2011a ).
Cancer Imaging
Because tumors generally have the same density as their surrounding tissues, contrast agents are necessary for tumor (6), 6957-6980.) identification and characterization by micro-CT. The vast majority of cancer imaging studies have been performed using blood pool nanoparticle contrast agents. Nanoparticles tend to accumulate in tumors due to the enhanced permeability and retention (EPR) effect (Maeda 2001 , Maeda et al. 2000 . Rapid angiogenesis within a tumor leads to the development of immature, poorly organized, leaky vasculature. Gaps in this leaky vasculature are large enough that nanoparticles (up to 300 nm) can extravasate into the tumor tissue. Tumors also tend to have very poorly developed lymphatic drainage, so the nanoparticles are not cleared from the tumor once they extravasate. This effect leads to the gradual passive accumulation of nanoparticles in the tumor perivascular space over the course of hours to days. EPR has been widely exploited for both tumor imaging and therapy using nanoparticle agents. Using micro-CT, dynamic biodistribution of contrast agent within small animal tumor models can be tracked. A liposomal iodine contrast agent was used in a rabbit tumor model for contrast agent tracking and biodistribution analysis (Zheng et al. 2009 ). Quantitative analysis was performed to determine the percent contrast agent uptake within each organ, including the tumor. Liposomal iodine was also used in two mouse models of breast cancer to demonstrate dynamic changes in enhancement within tumor vasculature and tumor parenchyma (Samei et al. 2009 . Immediately after injection, the contrast agent is entirely contained within the vasculature, with no significant enhancement within the tumor tissue. This early phase allows for the analysis of tumor vascular morphology, location, and density. After the contrast agent is cleared from the bloodstream, late-phase imaging can be performed to demonstrate the passive accumulation of the contrast agent in the tumors due to EPR. The tumors typically show heterogeneous enhancement throughout their volumes, demonstrating spatial heterogeneity in tumor perfusion and vascular permeability. A few studies have been done in mouse xenograft tumor models to carefully map the spatial and temporal distribution of liposome uptake by micro-CT (Ekdawi et al. 2015) , which has important implications for nanoparticle-based drug delivery. Figure 36 .12 shows an example of early-and delayedphase imaging using liposomal iodine-based contrast agent . Measurements of tumor vascular density in early-phase imaging and total contrast accumulation in late-phase imaging have also been used in two mouse models of lung cancer to differentiate different aggressiveness levels in tumors . Iodine-containing nanoparticle contrast agents have also been used for tumor imaging in two other models of lung cancer (Kindlmann et al. 2005 , Anayama et al. 2013 ) and a mouse model of liver cancer (Rothe et al. 2015) . Gold nanoparticles have also been used for passive tumor targeting in mouse models of breast and brain cancer (Hainfeld et al. 2006 (Hainfeld et al. , 2013 .
Micro-CT with Active Targeting
Beyond the passive targeting of nanoparticles to the reticuloendothelial system or tumors, active targeting of nanoparticles can be accomplished by conjugating specific ligands to the nanoparticle surface which can then link to their binding partners in vivo (Erathodiyil and Ying 2011) . Typically, these binding partners are cellular receptors or extracellular matrix proteins that are overexpressed in a pathological condition, so binding is specific to the region of pathology. Potential ligands for conjugation to the nanoparticle surface include antibodies, antibody fragments, other proteins, peptides, aptamers, lipids, carbohydrates, and other small molecules. The use of targeted contrast agents for micro-CT has recently been reviewed (Li et al. 2014 ). Gold nanoparticles have been used extensively for active targeting due to the ease of gold surface modification via gold-thiol bond formation. Gold nanoparticles have been used as a micro-CT contrast agent for the targeting of multiple tumor markers, including Her2 (Hainfeld et al. 2011) , the gastrin-releasing peptide (GRP) receptor (Chanda et al. 2010) , the epidermal growth factor receptor (EGFR) (Reuveni et al. 2011) , the folic acid receptor (FAR) (Wang et al. 2013) , and tumor microcalcifications (Cole et al. 2014) . Figure 36 .13 demonstrates the use of EGFR-antibody conjugated gold nanoparticles to target an EGFR-expressing subcutaneous tumor. Tumor enhancement was significantly increased with targeted gold nanoparticles compared to non-targeted gold nanoparticles (190 HU vs. 78 HU) .
Gold nanoparticles have also been used for CT imaging of lymph nodes by targeting CD4 (Eck et al. 2010 ), imaging of inflammation by targeting intravascular E-selectin (Wyss et al. 2009 ), imaging of atherosclerosis by targeting fibrin (Winter et al. 2005) , imaging of myocardial scars by targeting collagen (Danila et al. 2013) , and imaging of other cardiovascular disease (Ghann et al. 2012) . In addition to targeting by the surface conjugation of a ligand, some nanoparticles have inherent targeting abilities due to their nanoparticle chemistry. Gold nanoparticles encapsulated within high-density lipoprotein (HDL) particles are naturally recognized by HDL (Cormode et al. 2010) . Exia-160 consists of iodinated molecules that can be fully metabolized by the body, and therefore it accumulates in metabolically active tissues, including the myocardium and brown adipose tissue. This effect has been used to discriminate between healthy and infarcted myocardium (Ashton et al. 2014a ).
Multi-Modality Imaging
Micro-CT can be used together with other imaging modalities in order to better study functional molecular and anatomical information simultaneously. A micro-CT system can be combined with single photon emission computed tomography (SPECT), positron emission tomography (PET), or fluorescence molecular tomography (FMT) into a single unit (Goertzen et al. 2002 , Liang et al. 2007 ). SPECT, PET, and FMT are all highly sensitive, so targeted molecular imaging with radio-labeled or fluorescently-labeled small molecules or biomolecules is readily accomplished. However, these modalities are all limited by poor spatial resolution and poor anatomical imaging. By combining these systems with micro-CT, high-resolution anatomical images can be co-registered with molecular images to produce highly useful datasets. Combining micro-SPECT and micro-PET with micro-CT can also improve the image quality of the resultant SPECT and PET images by allowing for attenuation correction (Chow et al. 2005, Hwang and Hasegawa 2005) . Figure 36 .14 shows a combined micro-CT/micro-PET image for a 4T1 breast tumor-bearing mouse after injections of both liposomal iodine and 18 F-fluorodeoxyglucose. The multi-modal imaging took place 72 hours post-injection of the liposomal CT contrast agent. Note the co-localization of the EPR-based accumulation of the iodinated liposomes visualized by micro-CT and the FDG uptake in the micro-PET image. A second application of multi-modal imaging, which has gained much attention recently, is the use of agents that produce contrast for multiple imaging modalities simultaneously. Thus, multiple imaging modalities can be used after injection of a single contrast agent. This helps to improve registration between the different modalities and increase the amount of information gained from hybrid imaging systems. Many different formulations of multi-modal contrast agents have been developed, and the development of these agents has been reviewed previously (Key and Leary 2014) . Combined CT/MR contrast agents have been developed using gadolinium chelates conjugated to gold nanoparticles (Alric et al. 2008) or gold nanoshells (Coughlin et al. 2014) , liposomes containing both gadolinium and iodinebased contrast agents (Zheng et al. 2006) , and iron oxide core nanoparticles surrounded by either a gold shell (Carril et al. 2014) or a mesoporous silica shell filled with iodinated oil (Xue et al. 2014) . A combined CT/SPECT agent has been developed using a dendrimer linked to both iodinated organic molecules and SPECT agent chelators (Criscione et al. 2011) . A combined PET/CT agent has been demonstrated using gold nanoparticles conjugated to both glucose and 18 F-fluorodeoxyglucose (FDG) for targeting of metabolically active tumors (Roa et al. 2012 , Feng et al. 2014 ). All of these formulations have been successfully tested in vivo with multi-modal small animal imaging.
Theranostics
Many nanoparticles used as micro-CT contrast agents can easily be adapted to provide, or incorporate, therapeutics thus serving in theranostics. Gold nanoparticles, for example, have the Increased CT enhancement was seen for both types of nanoparticles, but targeted nanoparticles showed significantly higher enhancement than non-targeted controls. (Reprinted from Reuveni, T. et al. 2011 . Int J Nanomedicine 6, 2859 -2864 inherent ability to increase the effectiveness of radiation therapy because they absorb therapeutic X-rays efficiently and then release that energy to the surrounding tissues, thus increasing the locally delivered dose in regions of high nanoparticle concentration. This radiation augmentation has been studied by several groups to effectively treat cancer in multiple animal models (Hainfeld et al. 2004 , 2013 , Jeremic et al. 2013 , Park et al. 2015 , Wolfe et al. 2015 . Gold nanoparticles also exhibit high absorbance of light at their surface plasmon resonance wavelength, which can be tuned by altering the shape and size of the nanoparticle. For many gold nanoparticle shapes (i.e., nanorods, nanoshells, nanostars), this plasmon resonance occurs in the near infrared region, which is optimal for use with photothermal heating. In photothermal heating, nanoparticles convert laser light into heat, which leads to local hyperthermia. This effect can be used for tumor ablation. The use of nanoparticles for combined CT imaging and photothermal therapy has been recently reviewed (Curry et al. 2014) . Gold nanorods (Huang et al. 2011 ) and hollow gold nanoshells (Park et al. 2015) have both been used for combined CT imaging, radiation therapy, and photothermal therapy. Figure 36 .15 shows a gold nanostar theranostic probe that was used for CT imaging and photothermal therapy in a mouse model of primary soft tissue sarcoma . This probe showed high tumor accumulation and CT enhancement, as well as effective tumor ablation following photothermal therapy. Therapeutics can also be incorporated into nanoparticles by direct conjugation to the nanoparticle surface or by co-encapsulation of the therapeutic with the imaging agent (e.g., within the aqueous core of a liposome). Both methods have been used for the addition of therapeutic radioisotopes or chemotherapeutics to nanoparticle contrast agents , Lu 2014 , Ryu et al. 2014 , Zhu et al. 2014 ).
Spectral Micro-CT
Spectral information can improve contrast discrimination in CT imaging. In traditional CT imaging, the overall attenuation of X-ray intensity is measured by the detector, but the detected X-rays are not spectrally resolved. The spectrum of transmitted X-rays is important because the absorption of X-rays by different materials is highly dependent on X-ray energy, so the transmitted X-ray spectrum depends on what materials are present along the X-ray path. Therefore, there is a significant amount of information that can be gained by including spectral data in the CT reconstruction process. Based on differences in X-ray absorption, multiple materials can be differentiated and quantified within a single scan using spectral CT. There are two primary methods used to obtain spectral CT data. The first method, dual energy (DE) CT, uses X-ray sources with two different energy spectra and traditional energy integrating X-ray detectors. The second method uses a single X-ray source, but has energy-resolving detectors (photon-counting detectors) that can measure the energy of each detected photon. Dual energy CT is currently used clinically and has been successful in improving imaging for a variety of applications (Jepperson , Aran et al. 2014 , Bongartz et al. 2014 , Ohana et al. 2014 , Paul et al. 2014 . DE CT can use either a single X-ray source, which rapidly switches between two tube voltages, or two separate sources/ detectors which are orthogonally positioned and each operate at a different voltage. In either case, X-ray projections are acquired at each rotation angle using both X-ray sources. Additionally, a sandwich detector is sometimes used to separate low-energy and high-energy X-rays. In DE CT, two complete CT datasets are acquired for two different X-ray energy spectra. Most of a subject's body appears the same on both images, because absorption of X-rays by low atomic weight materials, which is primarily due to Compton scattering, is very weakly dependent on X-ray energy. However, the photoelectric effect in high atomic weight materials is highly dependent on X-ray energy. Therefore, the attenuation coefficient of high atomic weight materials (calcium in bone, iodine, gold) will depend on the energy spectrum of the incident X-rays. This effect is particularly pronounced if the two energy spectra fall on either side of the k-edge for one of the materials. Because there is a large increase in attenuation at energies above the k-edge, this leads to a large difference in signal between the two scans. By combining data from the two energy sets, these high Z materials can be differentiated from one another and quantified.
Spectral separation using DE CT is somewhat limited by our ability to minimize the overlap of X-ray spectra using polychromatic sources. The separation between the two energy spectra can be improved by applying additional filtration to the X-ray tubes, which can preferentially remove low-energy photons and further increase the average energy of the X-ray spectrum. The other limitation for DE CT is its ability to discriminate between closely-related elements, for example, barium and iodine.
Using this method, DE micro-CT has been used successfully for a variety of applications in mice. DE micro-CT was used for atherosclerosis imaging to differentiate liposomal iodine accumulated in plaque macrophages from calcium within the plaque (Bhavane et al. 2013) . Iodine accumulated within the myocardium has been separated from other soft tissues and from calcium in the bone for imaging of myocardial infarction (Ashton et al. 2014a) . DE micro-CT has been used to separate gold nanoparticles accumulated within soft-tissue sarcomas or primary lung tumors (Ashton et al. 2014b ) from liposomal iodine within the vasculature. In these studies, the simultaneous measurement of two different nanoparticle concentrations was used to calculate tumor vascular density and vascular permeability. This process is demonstrated in Figure 36 .16, which shows scans of sarcoma tumors in a mouse that was injected first with gold nanoparticles and 72 hours later with iodinated liposomes. The dual energy micro-CT was performed using 40 and 80 kVp. Following the acquisition, two 3D images were reconstructed. These two scans were then mathematically decomposed into maps of iodine and gold concentrations .
Validation of DE micro-CT decompositions was performed using histology and ex vivo measurements of tissue gold and iodine concentrations (Ashton et al. 2014b) . In two additional studies, DE micro-CT was used to assess vascular changes following radiation therapy. In the first, the increase in vascular permeability in a soft-tissue sarcoma was determined by measuring accumulation of liposomal iodine ). In the second study, cardiac injury following radiation therapy was assessed using gold nanoparticles and liposomal iodine . Our Duke group has recently also demonstrated triple-energy micro-CT for the differentiation of three materials: gold, iodine, and gadolinium. Using a novel algorithm called spectral diffusion , these three materials were successfully separated and quantified both in an in vitro phantom and in vivo.
Although PCXDs are still experimental for clinical CT, their use in preclinical small animal studies has been successfully demonstrated. Spectral CT has been used with targeted nanoparticles to image atherosclerotic plaques (Cormode et al. 2010) . Gold nanoparticles were encapsulated within HDL particles to target plaque macrophages. A preclinical spectral CT system (Phillips Research, Hamburg) was used to differentiate the gold from iodine, calcium, and soft tissues. Spectral micro-CT was used to resolve the signals from gold, iodine, and calcium within the tissue phantom matrix. The spectral micro-CT system successfully differentiated the phantom regions containing gold, iodine, and calcium, with very little overlap between the signals. They also tested the targeting of their gold-HDL particles in a mouse model of atherosclerosis. Spectral micro-CT (and subsequent histology) demonstrated that the gold successfully accumulated within the plaques and that gold could be discriminated from iodine, calcium, and soft-tissue in vivo. The same HDLencapsulated gold nanoparticles have been used along with a blood pool iodine contrast agent to simultaneously image the signals from gold accumulated within lymph nodes, and iodine within the blood, bone, and soft tissue . Gold nanoparticles accumulating in lymph nodes after subcutaneous injection have been differentiated from soft tissue and bone . Iodine within the vasculature and barium within the GI tract have been imaged and differentiated from bone and soft tissue (Anderson et al. 2010) . Spectral imaging has also been used to detect novel ytterbium nanoparticles within the vasculature ) and organic bismuth nanocolloids targeted to fibrin-rich clots (Pan et al. 2010) . In both cases, spectral CT was used to differentiate contrast agent signal from soft tissue and bone. The primary limitation in all of these studies was that the low photon-count rate limitations of the PCXD system resulted in a long scan time. Because the scan time was so long, the imaging was done after sacrificing the animals in order to prevent motion over the course of the long acquisition. Despite the limitations, these studies demonstrate that spectral CT using a PCXD system has the potential for high-quality in vivo imaging and material discrimination. Some technical problems remain to be solved, but PCXD systems have great promise for use in both preclinical and clinical CT imaging.
Phase Contrast Micro-CT Imaging
Micro-CT creates the perfect environment for the development of phase contrast CT imaging. For most micro-CT applications, X-ray photons are treated as particles. Treating X-rays instead as electromagnetic waves, their complex index of refraction is expressed as n = 1 -δ -iβ, which relates to the linear absorption coefficient, µ 0 , as β = µ 0 *(λ/4π) and to the coefficient of phase change, η, as δ = η*(λ/2π) for X-ray wavelength, λ. For diagnostic X-rays (10-100 keV) and low atomic number elements (Z ≤ 20), δ is approximately two to three orders of magnitude larger than β and falls off more slowly with increasing X-ray energy (∼1/E 2 vs. ∼1/E 3 ). Because of these factors, phase contrast is interesting for imaging soft biological tissues without the need for exogenous contrast agents and with potentially reduced radiation dose (Momose 2005 , Bravin et al. 2013 ). These theoretical advantages have been practically validated using monochromatic, synchrotron X-ray sources and one of several imaging schemes, including (1) propagation-based, (2) analyzer-crystal-based, and (3) grating interferometer-based phase contrast. Propagation-based phase contrast imaging relies on the propagation distance of X-rays after they have been refracted within the sample (i.e., on the object-to-detector distance). Rotating the sample and acquiring projections at a single distance allows reconstruction of hybrid, edge-enhanced data in which the absorption information is augmented by the Laplacian of the refractive index. Explicit phase and absorption retrieval are possible by acquiring the projections at several object-to-detector distances followed by algorithmic post-processing (Langer et al. 2008) . Analyzer-crystal-based methods rely on Bragg diffraction within a silicon single crystal. Acquiring projections with a fixed sample position as the angle of the analyzer crystal is varied with respect to the X-ray beam exiting the sample yields a rocking curve (crystal angle vs. recorded intensity) from which refraction and apparent absorption projections can be recovered (Chapman et al. 1997 ). Grating interferometer-based phase contrast methods use aligned, micron-scale gratings to generate systematic interference fringes in the propagating X-ray wavefront. Refraction within the sample shifts the interference fringes, allowing recovery of the differential of phase shifts caused by the object from intensity curves generated by stepping the sample or a component grating through a grating period (phase stepping), while the sample position remains fixed (David et al. 2007) .
One of the primary challenges in translating these phase contrast imaging methods from synchrotron beam lines to routine clinical and preclinical application is the comparatively low brilliance and low coherence of laboratory X-ray sources; however, technological developments is this area are very promising. Pfeiffer et al. have demonstrated the effective translation of the Talbot-Lau grating interferometer from a synchrotron source to a polychromatic X-ray tube source through the addition of a source grating, which collimates the source beam into an array of individually coherent X-ray line sources (Pfeiffer et al. 2006) . They have also demonstrated the recovery of three contrast mechanisms with a single scan (absorption contrast, differential phase contrast, and dark field scatter contrast) ) and have developed a prototype small animal scanner in collaboration with Bruker micro-CT (Tapfer et al. 2012 . Additionally, they have demonstrated the potential value of differential phase contrast and dark field imaging in several applications, including cancer identification and classification ) and lung imaging (Meinel et al. 2014) .
As an alternative to the Talbot-Lau interferometer with source grating, a non-interferometric, grating-based approach for differential phase contrast with a laboratory source, called coded aperture X-ray phase contrast imaging, has been proposed and demonstrated using a physical phantom (Munro et al. 2012) . Additional work has been done with an analyzer crystal-based setup and a laboratory source (Connor et al. 2011) .
Several technical challenges must be overcome prior to the widespread adoption of phase contrast imaging. High-quality tomographic reconstructions of differential phase contrast data using a Talbot-Lau grating interferometer can require hours to tens of hours of scanning owing to the flux limitations associated with laboratory X-ray sources, which are exacerbated by collimator-like phase gratings, and owing to the phase-stepping performed at each sample rotation angle (Fu et al. 2014) . A single-shot alternative to phase-stepping, which uses Moiré patterns and Fourier analysis, has been demonstrated using a physical phantom and could lead to significantly reduced scan times (Bevins et al. 2011) . Phase wrapping in thick specimens and bone poses a significant hurdle for preclinical and clinical imaging; however, algorithms have already been proposed and demonstrated for phase unwrapping (Tapfer et al. 2012 , Epple et al. 2013 . Additional fabrication challenges are associated with scaling the field-of-view and viable energy range for grating interferometers. Proposed solutions to these problems include helical scanning (Fu et al. 2014 ) and inclining the gratings with respect to the beam direction for reduced transmittance of high-energy photons (Stutman et al. 2013) , respectively.
In addition to technological developments, the adaptation of iterative reconstruction algorithms to the problem of tomographic phase contrast image reconstruction will reduce associated scanning times and radiation dose. Some work has been presented in the literature illustrating how existing iterative CT reconstruction algorithms can be modified for this purpose (Köhler et al. 2011 . Furthermore, techniques for enforcing gradient sparsity in phase contrast data have been demonstrated (Nilchian and Unser 2012, Herzen et al. 2014) . Figure 36 .17 is adapted from Tapfer et al. 2013 and compares phase and absorption contrast results using a synchrotron and laboratory source in a mouse model of pancreatic ductal adenocarcinoma. The authors have used a grating-based phase contrast CT method. It was found both visually and quantitatively by means of contrast to noise ratio that the increased soft tissue contrast apparent in phase images does allow for tumor identification, unlike in the attenuation images. Note that the quality of images acquired with a conventional X-ray tube is not much inferior to the synchrotron acquisition.
Radiation Dose
One of the major limitations of X-ray CT imaging is exposure to radiation. High radiation doses are required for high-resolution CT scans. Signal-to-noise ratio in CT is inversely proportional to the square root of the number of X-rays passing through each voxel. As voxel size decreases, the number of X-rays necessary to maintain a constant signal-to-noise ratio increases significantly. In planning micro-CT studies, a balance must be made between desired image quality and radiation exposure.
X-ray radiation exposure can lead to biological damage and long-term health effects ). The LD 50/30 radiation dose in mice (the dose required to kill 50% of mice within 30 days) depends on many factors, but tends to be between 5 and 8 Gy (Ritman 2004 , Carlson et al. 2007 ). The typical radiation dose for a single micro-CT scan can vary widely and reported values in the literature range from 0.017-0.78 Gy (Carlson et al. 2007 ). Rodents have the ability to repair damage from low doses of radiation (∼0.3 Gy) over the course of several hours (Parkins et al. 1985) , so most low-dose micro-CT scans should have limited biological impact, even when the same animals are longitudinally scanned over the course of a study. But, for higher-dose scans, longitudinal imaging can potentially lead to a cumulative dose that could affect biological function (particularly immune function and tumor response) and long-term health . Therefore, careful consideration must be made to determine the optimal imaging protocol for each individual application to minimize the effects of radiation dose on the experiment. With additional advances in micro-CT technology and reconstruction algorithms, radiation doses should further decrease, which will help to overcome radiation as a limitation of micro-CT imaging.
Conclusions
Micro-CT has become an extremely important tool in small animal research. Micro-CT produces non-invasive, 3D, highresolution anatomical images, which can provide a wealth of information about normal animal function and pathology. The increasing availability and low cost of micro-CT scanners (compared, for example, to MRI scanners) greatly increases the use and impact of micro-CT imaging on small animal studies. Radiation dose is a limitation in micro-CT imaging, but can be reduced with better technology and more sophisticated image reconstruction algorithms. Although X-ray micro-CT is limited by low tissue contrast, developments in contrast agent design show great promise for use in imaging a wide range of organ systems and pathologies. Additional new developments in spectral and phase contrast imaging will further improve the usefulness of micro-CT in acquiring functional and molecular information. This will greatly expand the potential applications for micro-CT in small animal research.
